These outcomes, along with a past report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 help the strategy of focusing on ACKR3 as a singular solution to modulate the opioid method, which could open up new therapeutic avenues for opioid-associated Diseases. At that point, Microsoft https://augustinef802yrm8.livebloggs.com/profile